Cullinan Therapeutics (CGEM) Non Operating Income: 2020-2024
Historic Non Operating Income for Cullinan Therapeutics (CGEM) over the last 5 years, with Dec 2024 value amounting to -$199,000.
- Cullinan Therapeutics' Non Operating Income fell 139.26% to -$117,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $239,000, marking a year-over-year increase of 305.08%. This contributed to the annual value of -$199,000 for FY2024, which is 183.26% down from last year.
- According to the latest figures from FY2024, Cullinan Therapeutics' Non Operating Income is -$199,000, which was down 183.26% from $239,000 recorded in FY2023.
- In the past 5 years, Cullinan Therapeutics' Non Operating Income ranged from a high of $239,000 in FY2023 and a low of -$199,000 during FY2024.
- Moreover, its 3-year median value for Non Operating Income was $57,000 (2022), whereas its average is $32,333.
- Its Non Operating Income has fluctuated over the past 5 years, first skyrocketed by 812.50% in 2022, then tumbled by 183.26% in 2024.
- Cullinan Therapeutics' Non Operating Income (Yearly) stood at -$11,000 in 2020, then rose by 27.27% to -$8,000 in 2021, then spiked by 812.50% to $57,000 in 2022, then soared by 319.30% to $239,000 in 2023, then plummeted by 183.26% to -$199,000 in 2024.